Cargando…
WT1基因在急性髓系白血病微小残留病监测中的应用
OBJECTIVE: To probe the potential utility of Wilms tumor 1 (WT1) as a marker of minimal residual disease (MRD) in acute myeloid leukemia (AML) to estimate the relapse-predicting cut-off value. METHODS: Quantitative assessment of bone marrow WT1 mRNA level was preformed using real-time quantitative r...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348239/ https://www.ncbi.nlm.nih.gov/pubmed/28954349 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2017.08.009 |